FDA and Philip Morris

Paper Summary:

This paper discusses several key facets of the tobacco controversy. It discusses Philip Morris' role in the controversy, particularly the case of tobacco giant Philip Morris and issues of liability and ethics. It examines the Food and Drug Administration's (FDA) role and discusses regulated tobacco. The paper also discusses the evolution of Philip Morris' product management strategy and its success.

Table of Contents:
Introduction
A Journey from the Tobacco Wars to the Master Settlement Agreement
Has Philip Morris "Done Well by Doing Good"?
The Evolution of Philip Morris' Product Management Strategy
The Market Failure of Tobacco
Is Regulated Tobacco Still Deadly?
How Do Tobacco Executives Sleep at Night?
Conclusion

From the Paper:

"Philip Morris, whatever its motivations, has been able to overcome controversy and embrace drastic change for the company's overall betterment. Whatever one's feeling on whether or not tobacco companies should be able to exist at all, one thing is certain-it is possible for companies to responsibly sell potentially dangerous products, and in the final analysis, it is up to the consumer to choose them or not. In this way, the market-and not bureaucrats or lawyers-dictate the ebb and flow of free markets, and show every indication of doing so in the future as well."

Sample of Sources Used:

• Gostin, L. O. (2005, Spring). Law and the Public's Health: The Legal System Provides Many Tools to Promote Public Health, but It Includes Necessary Limits to Protect Individual Rights. Issues in Science and Technology, 21, 71+.
• Jones, R. M. (1997). Strategic Management in a Hostile Environment: Lessons from the Tobacco Industry. Westport, CT: Quorum Books.
• Kessler, D. (2001). A Question of Intent: A Great American Battle with a Deadly Industry. New York: Public Affairs.
• Nocera, Joe. (2006, June 18). If It's Good for Philip Morris, Can it Also be Good for Public Health? New York Times Online: www.nytimes.com/2006/06/18/magazine/18tobacco.html.
• Rabin, R. L. & Sugarman, S. D. (Eds.). (2001). Regulating Tobacco. New York: Oxford University Press.

More papers on FDA and Philip Morris:

• Analytical Essay # 122876 : "Philip Morris USA versus Williams"
• Term Paper # 145169 : "Organizational Values of Philip Morris/Altria"
• Analytical Essay # 112218 : "Philip Morris"

APA Citation:

MLA Citation: